TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05380557

ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Low site engagement and accrual”

The sponsor’s own words in the registry.

Life of this trial

202120222023Started2021-08-23Registered2022-04-01Stopped2022-09-06

Vital statistics

Status
Terminated
Sponsor
Invitae Corporation
Sponsor type
Industry
Conditions
Pancreatic Adenocarcinoma; Pancreatic Cancer; Resectable Pancreatic Cancer
Interventions
Germline genetic testing
Participants
2
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.